CANCER IMMUNOTHERAPY AND TUMOR IMMUNOLOGY RESEARCH BUILDING
100,540 sq. ft. Research Laboratory & Academic Building
$60MM New-Build Project
This new building is being developed to house the newly formalized division of Cancer and Immunotherapeutics and Tumor Immunology (CITI) at City of Hope. The CITI division will integrate a multidisciplinary group of scientists and physicians with a translational research mandate. They are establishing a center of research excellence in the field of Cancer Immunotherapeutics designed to attact world-class researchers in the fields of radioimmunotherapy, cellular immunotherapy, molecular immunotherapy, vaccine immunotherapy and transplant immunotherapy to explore the potential of the body's natural defenses against infection in the fight against cancer. This center will allow researchers to practice the "bench to bedside" method of developing new drugs, conducting clinical trials and administering those drugs to hospital patients.
The five-story building will house research labs, laboratory support spaces and equipment rooms, a radiopharmacy suite, a cGMP-compliant T-cell production plant, faculty offices, space for post-docs, administrative and regulatory affairs groups, break and conference rooms, and all necessary infrastructure to support this program.
The CITI Building will also include the City of Hope's Graduate School of Biological Sciences Academic Center, which will include the Dean's suite, an auditorium, classrooms, student gathering areas, study rooms, a library, and a dining facility.
This construction project broke ground in Spring 2007. The CITI Building is scheduled to open its doors in Fall 2009.